Bibliographic Info
GuidelineConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2016
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Moderate
In settings where malaria and/or severe bacterial infections are highly prevalent, cotrimoxazole prophylaxis should be continued regardless of CD4 cell count or WHO clinical stage.
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Year2014
InstitutionWorld Health Organization
Guideline
WHO guidelines on the management of advanced HIV disease
Year2025
InstitutionWorld Health Organization